IE39872B1 - 1 3-oxygenated 8a-oestratrienes - Google Patents
1 3-oxygenated 8a-oestratrienesInfo
- Publication number
- IE39872B1 IE39872B1 IE1461/74A IE146174A IE39872B1 IE 39872 B1 IE39872 B1 IE 39872B1 IE 1461/74 A IE1461/74 A IE 1461/74A IE 146174 A IE146174 A IE 146174A IE 39872 B1 IE39872 B1 IE 39872B1
- Authority
- IE
- Ireland
- Prior art keywords
- compounds
- oestratrienes
- oxygenated
- oestraoligoene
- gb1479934a
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 abstract 3
- 150000002148 esters Chemical class 0.000 abstract 2
- 239000004215 Carbon black (E152) Substances 0.000 abstract 1
- 206010030247 Oestrogen deficiency Diseases 0.000 abstract 1
- 238000010494 dissociation reaction Methods 0.000 abstract 1
- 230000005593 dissociations Effects 0.000 abstract 1
- 230000001076 estrogenic effect Effects 0.000 abstract 1
- 125000001033 ether group Chemical group 0.000 abstract 1
- 150000002170 ethers Chemical class 0.000 abstract 1
- 230000002349 favourable effect Effects 0.000 abstract 1
- 229930195733 hydrocarbon Natural products 0.000 abstract 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 abstract 1
- 150000002902 organometallic compounds Chemical class 0.000 abstract 1
- 125000001424 substituent group Chemical group 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
- C07J1/0051—Estrane derivatives
- C07J1/0066—Estrane derivatives substituted in position 17 beta not substituted in position 17 alfa
- C07J1/007—Estrane derivatives substituted in position 17 beta not substituted in position 17 alfa the substituent being an OH group free esterified or etherified
- C07J1/0074—Esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
- C07J1/0051—Estrane derivatives
- C07J1/0059—Estrane derivatives substituted in position 17 by a keto group
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J15/00—Stereochemically pure steroids containing carbon, hydrogen, halogen or oxygen having a partially or totally inverted skeleton, e.g. retrosteroids, L-isomers
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J31/00—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring
- C07J31/006—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring not covered by C07J31/003
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
- C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
- C07J41/0072—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 the A ring of the steroid being aromatic
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J43/00—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton
- C07J43/003—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton not condensed
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- Urology & Nephrology (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Steroid Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Catalysts (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE2336431A DE2336431C2 (de) | 1973-07-13 | 1973-07-13 | 1.3-oxygenierte 8 alpha-Östratriene, Verfahren zu deren Herstellung und diese enthaltende Arzneimittel |
| DE19742426777 DE2426777A1 (de) | 1974-05-31 | 1974-05-31 | 1.3-oxygenierte 8 alpha-oestratriene |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| IE39872L IE39872L (en) | 1975-01-13 |
| IE39872B1 true IE39872B1 (en) | 1979-01-17 |
Family
ID=25765510
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IE1461/74A IE39872B1 (en) | 1973-07-13 | 1974-07-11 | 1 3-oxygenated 8a-oestratrienes |
Country Status (18)
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2551214C2 (de) * | 1975-11-12 | 1984-07-12 | Schering AG, 1000 Berlin und 4709 Bergkamen | Verfahren zur Herstellung von 1,3-oxygenierten 8α-Östratrienen |
| JPS5862734U (ja) * | 1981-10-22 | 1983-04-27 | 日工株式会社 | 型枠支持サボ−ト |
| JPS59146759A (ja) * | 1984-01-06 | 1984-08-22 | 株式会社日立製作所 | 自動ねじ込み装置 |
| JPS60155376A (ja) * | 1984-01-24 | 1985-08-15 | 松下電器産業株式会社 | ナツト浮き検出装置 |
| DE3710728A1 (de) * | 1987-03-31 | 1988-10-13 | Schering Ag | Verfahren zur herstellung von 17(alpha)-ethinyl-17ss-hydroxy-18-methyl-4,15-estradien-3-on und die neuen zwischenprodukte fuer dieses verfahren |
| US6476011B1 (en) | 1991-08-28 | 2002-11-05 | Sterix Limited | Methods for introducing an estrogenic compound |
| US6903084B2 (en) | 1991-08-28 | 2005-06-07 | Sterix Limited | Steroid sulphatase inhibitors |
| US6011024A (en) | 1991-08-28 | 2000-01-04 | Imperial College Of Science Technology & Medicine | Steroid sulphatase inhibitors |
| US7335650B2 (en) | 2000-01-14 | 2008-02-26 | Sterix Limited | Composition |
| GB0020498D0 (en) | 2000-08-18 | 2000-10-11 | Sterix Ltd | Compound |
| RU2679625C1 (ru) * | 2018-11-08 | 2019-02-12 | Ильясов Шамиль Сионович | ПРИМЕНЕНИЕ 3-О-СУЛЬФАМОИЛОКСИ-6-ОКСА-7β-МЕТИЛ-D-ГОМО-8α-ЭСТРА-1,3,5(10)-ТРИЕН-17а-ОНА ДЛЯ ЛЕЧЕНИЯ РАКА МОЛОЧНОЙ ЖЕЛЕЗЫ, ВКЛЮЧАЯ ТРИЖДЫ-НЕГАТИВНУЮ ФОРМУ, И СПОСОБ ЕГО ПОЛУЧЕНИЯ |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3436411A (en) * | 1967-12-28 | 1969-04-01 | American Home Prod | Process for cleaving an a-ring ether group in 13-alkylgona (and 8-isogona)-1,3,5(10)-trienes and delta-7-,delta-8(9)-,and delta-8(9),14(15)-dehydro derivatives thereof |
-
1974
- 1974-07-09 DK DK368074A patent/DK133051C/da not_active IP Right Cessation
- 1974-07-11 AU AU71123/74A patent/AU477010B2/en not_active Expired
- 1974-07-11 SE SE7409151A patent/SE7409151L/xx unknown
- 1974-07-11 AT AT575574A patent/ATA575574A/de not_active Application Discontinuation
- 1974-07-11 DD DD179870A patent/DD114066A5/xx unknown
- 1974-07-11 IE IE1461/74A patent/IE39872B1/xx unknown
- 1974-07-12 HU HU74@@E480A patent/HU169791B/hu unknown
- 1974-07-12 JP JP49080116A patent/JPS5821639B2/ja not_active Expired
- 1974-07-12 CH CH964674A patent/CH609064A5/xx not_active IP Right Cessation
- 1974-07-12 CA CA204,667A patent/CA1030951A/en not_active Expired
- 1974-07-12 NO NO742546A patent/NO742546L/no unknown
- 1974-07-12 SU SU742043783A patent/SU626705A3/ru active
- 1974-07-12 CH CH1035978A patent/CH614217A5/xx not_active IP Right Cessation
- 1974-07-12 CS CS7600001694A patent/CS182300B2/cs unknown
- 1974-07-12 CS CS7400004984A patent/CS182260B2/cs unknown
- 1974-07-12 ES ES428226A patent/ES428226A1/es not_active Expired
- 1974-07-12 FI FI2139/74A patent/FI54131C/fi active
- 1974-07-14 IL IL45259A patent/IL45259A/en unknown
- 1974-07-15 FR FR7424499A patent/FR2236505B1/fr not_active Expired
- 1974-07-15 GB GB31241/74A patent/GB1479934A/en not_active Expired
Also Published As
| Publication number | Publication date |
|---|---|
| DK133051B (da) | 1976-03-15 |
| NO742546L (enrdf_load_html_response) | 1975-02-10 |
| AU7112374A (en) | 1976-01-15 |
| FI213974A7 (enrdf_load_html_response) | 1975-01-14 |
| GB1479934A (en) | 1977-07-13 |
| ES428226A1 (es) | 1976-07-16 |
| ATA575574A (de) | 1978-05-15 |
| CH609064A5 (en) | 1979-02-15 |
| FR2236505B1 (enrdf_load_html_response) | 1977-07-08 |
| JPS5032160A (enrdf_load_html_response) | 1975-03-28 |
| SU626705A3 (ru) | 1978-09-30 |
| SE7409151L (sv) | 1975-01-14 |
| CA1030951A (en) | 1978-05-09 |
| CS182260B2 (en) | 1978-04-28 |
| FI54131C (fi) | 1978-10-10 |
| CH614217A5 (en) | 1979-11-15 |
| IL45259A (en) | 1977-10-31 |
| DK368074A (enrdf_load_html_response) | 1975-03-17 |
| FI54131B (fi) | 1978-06-30 |
| IE39872L (en) | 1975-01-13 |
| CS182300B2 (en) | 1978-04-28 |
| DD114066A5 (enrdf_load_html_response) | 1975-07-12 |
| HU169791B (en) | 1977-01-28 |
| IL45259A0 (en) | 1974-10-22 |
| AU477010B2 (en) | 1976-10-14 |
| FR2236505A1 (enrdf_load_html_response) | 1975-02-07 |
| JPS5821639B2 (ja) | 1983-05-02 |
| DK133051C (da) | 1976-08-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IE39872L (en) | 1, 3- oxygenated 8 ó- oestratrienes. | |
| GB1476215A (en) | Dibenzoxepin derivatives process for the preparation thereof and pharmaceutical compositions containing them | |
| GB1530913A (en) | Copying materials | |
| GB1445956A (en) | Esters of dihydroapovincaminic acid | |
| IE40429L (en) | 11ß-ALKYL STEROIDS OF THE ESTRANE SERIES. | |
| GB1479362A (en) | 3,17,18-trihydroxy-1,3,5(10)-oestratrienes and their derivatives | |
| ES425088A1 (es) | Procedimiento para preparar resinas acidas. | |
| GB1360164A (en) | 3,5-dialkyl-4-hydroxyphenylalkanoic acid esters of hydroxyalkyl hydroxyalkanoates | |
| GB1277264A (en) | 07-acetylgonanes and derivatives therefor | |
| JPS57206616A (en) | Menses inducer, feticidal or odynopoeia containing prostaglandin e1 analog | |
| GB1325943A (en) | Mono-acetyl derivatives of antibiotic sf 837 and sf 837-a2 substances and production thereof | |
| ES436218A1 (es) | Procedimiento para la obtencion de derivados de fenoxialca- nol. | |
| GB1308849A (en) | Process for the preparation of 6alpha-methyl-19-nor-pregnenes | |
| ES400163A1 (es) | Procedimiento para la preparacion de nuevos derivados de acido pregnanoico. | |
| GB1366664A (en) | 3 - /3 - cyanopropyl/ - cyclopenta /f/ /1/ benzopyrans and the preparation thereof | |
| GB1088621A (en) | Improvements in or relating to podophyllin derivatives | |
| GB1198146A (en) | 21-Ethers of 21-Hydroxy-delta<16>-Steroids of the Pregnane Series | |
| ES422841A1 (es) | Procedimiento de preparacion de esteres de 4-hidroxi-2,9- dioxatriciclo (4, 3, 03,7)-decanos. | |
| GB1435892A (en) | Aluminium complexes of guaiphenesin | |
| ES386351A1 (es) | Un procedimiento para la preparacion de compuestos de 19- nortestosterona. | |
| GB1260915A (en) | PROCESS FOR THE MANUFACTURE OF (ANDROST-17beta-YL)-alpha-PYRONES | |
| GB1415218A (en) | Oxabicyclononane and process for the manufacture htereof | |
| ES318808A1 (es) | Procedimiento para la fabricacion de nuevos alcoholes terciarios | |
| ES370227A1 (es) | Procedimiento para la preparacion de compuestos de triter- penoide. | |
| ES390920A1 (es) | Procedimiento para la preparacion de 4,5 alfa - oxido - gufa-20,22-dienolid-3-(ramnosido 2'83' - dialcohilortocarbo-natos). |